RAMM Pharma Corp. RAMM
CNSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.54M | -6.29M | -6.23M | -6.40M | -9.66M |
| Total Depreciation and Amortization | 338.30K | 357.80K | 439.90K | 522.20K | 640.70K |
| Total Amortization of Deferred Charges | 1.70K | 1.30K | 900.00 | 400.00 | 700.00 |
| Total Other Non-Cash Items | 2.50M | 3.32M | 2.96M | 3.22M | 6.15M |
| Change in Net Operating Assets | 2.78M | 1.44M | 2.02M | 1.91M | 1.72M |
| Cash from Operations | -918.20K | -1.17M | -812.10K | -753.10K | -1.14M |
| Capital Expenditure | -- | -- | 17.60K | 0.00 | -16.00K |
| Sale of Property, Plant, and Equipment | 691.50K | 769.10K | 1.26M | 862.90K | 593.10K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -5.00K |
| Cash from Investing | 691.50K | 769.10K | 1.28M | 862.90K | 572.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -69.80K | -69.80K | -101.20K | -145.50K | -214.20K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.70K | -8.60K | -8.60K | -8.60K | 16.40K |
| Cash from Financing | -52.40K | -56.90K | -78.60K | -109.40K | -141.50K |
| Foreign Exchange rate Adjustments | -4.10K | -5.60K | -27.90K | -8.40K | -7.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -283.10K | -460.10K | 357.90K | -7.80K | -714.20K |